Accelerating Science: How to cure the incurable with cell and gene therapy
ChanTest has the world's largest library of validated human ion channel assays and a growing portfolio of GPCR and transporter targets to serve the needs of its pharmaceutical and biotech customers. From functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process to a complete set of in vitro GLP and non-GLP services for preclinical cardiac risk assessment, ChanTest works in partnership with customers to cost-effectively speed the drug discovery and development process, and ultimately to help make better, safer drugs. For more in.... Read more

Functional cell-based assays provide more physiologically useful information compare...

ChanTest has the world's largest library of validated human ion channel assays and a growing portfolio of GPCR and transporter targets to serve the needs of its pharmaceutical and biotech customers.

From functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process to a complete set of in vitro GLP and non-GLP services for preclinical cardiac risk assessment, ChanTest works in partnership with customers to cost-effectively speed the drug discovery and development process, and ultimately to help make better, safer drugs.

For more information, visit us at www.chantest.com.